Safety and Efficacy of SFPP in Knee Osteoarthritis
Status:
Completed
Trial end date:
2021-01-11
Target enrollment:
Participant gender:
Summary
The objectives of this study are to demonstrate the non-inferiority of esflurbiprofen plaster
(SFPP) 40 mg applied for 2 weeks to diclofenac gel, the comparator, in terms of efficacy in
patients with knee osteoarthritis (OA) and to examine the safety of SFPP.